What We're Reading: Page 231
Industry reads hand-picked by our editors
Jun 14, 2019
-
FiercePharma
GSK may be reviving incentive pay for sales reps, but it's not returning to its old ways: executive
-
Boston Business Journal
Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy license
-
Bloomberg
AstraZeneca markets an herbal-based remedy to expand in China
-
Los Angeles Times
12 million pills and 700 deaths: How a few pill mills helped fan the U.S. opioid inferno
Jun 13, 2019
-
Science
University of California CRISPR researchers form drug discovery alliance with pharma giant
-
Forbes
Move over, Martin Shkreli: this pharma exec is accused of fixing prices on 107 drugs
-
Bloomberg
Teva Pharma's short sellers double down as legal woes drag on
-
Reuters
Dassault Systemes targets life sciences with $5.8 billion Medidata deal
Jun 12, 2019
-
Financial Times
Insys bankruptcy sets up opioid test case as US states seek cash
-
Scientific American
How nanotech powers precision medicine
-
STAT
Next up for KRAS-blocking cancer drugs: Big reveal from Mirati
-
The Wall Street Journal
Biotech Investors Need Bigger Targets
Jun 11, 2019
Jun 10, 2019
-
The Guardian
The race to replace Viagra
-
Quartz
How the former employees of Theranos explain themselves on LinkedIn
-
Genetic Engineering & Biotechnology News
New BIO chair vows crackdown on biopharma's "bad actors"
-
Kaiser Health News
How measles detectives work to contain an outbreak
Jun 07, 2019
-
Science
A missed Alzheimer's opportunity? Not so much
-
The New York Times
An Australian doctor's dream: Curing America's opioid curse
-
Newsweek
Gizmodo slams drug company with 'correction' for increasing anti-seizure medicine by nearly 100,000 percent
-
The Guardian
Big pharma is denying children like my son vital drugs. So I've set up a buyers club
Jun 06, 2019
-
A Missed Alzheimer’s Opportunity? Not So Much
-
STAT
A celebrated drug hunter went after Alzheimer's. Here's how he lost
-
The Boston Globe
Third Rock raises $770 million in new funding round
-
The New York Times
Trump Administration Sharply Curtails Fetal Tissue Medical Research
Previous
